Van Dask Kristin Lea

CFO Van Dask purchases 15,200 shares ($65.2K) at $4.29; 3 of 4 prior PSEC buys were well-timed at 90d; cluster pattern with 2 other insiders buying in past 14 days

Van Dask Kristin Lea, CFO, TREASURER, SECRETARY, and CCO, executed 2 separate purchases totaling 15,200 shares for $65,208.00 on 2024-11-12, expanding holdings by 21.1% to 87,245 shares. At this ticker specifically, her prior 4 open-market purchases show a 75% well-timed rate at the 90-day mark (3 of 4 trades preceded gains), including a June 2024 buy that suffered -75.9% over 90 days—the most recent being May 2024 or earlier. The current filing occurs within a cluster pattern where 2 other insiders also bought within the past 14 days, which may suggest coordinated conviction-building at a time when the stock trades at -29.8% from its 52-week high and carries negative fundamentals ($-134.0M net income). However, the company trades at an unusual P/E of 146.00, and the 90-day lookback (July–November) shows mixed timing outcomes at this ticker in prior periods, so this purchase lacks clear directional clarity from historical precedent alone.

CFO Kristin Lea Van Dask bought 3,330 shares of PSEC at $22.50 on 2024-06-20, tripling holdings to 4,539 shares; stock now at $5.62.

Van Dask, serving as CFO, Treasurer, Secretary, and Chief Compliance Officer, purchased 3,330 shares worth $74,925.00, increasing her position by 275.3% from 1,209 to 4,539 shares. This represents a substantial concentration of executive capital in a single position at $22.50—a price 300% above the current trading level of $5.62. Her prior trades at PSEC show consistent 90-day positive returns (ranging from +0.2% to +3.0%), establishing a pattern of timing purchases ahead of subsequent appreciation at this specific ticker. However, the company reported full-year net income was negative despite current-period net income of $144,361,000.00, and the stock trades at a P/E of 9.69 with a $2.3B market cap. The 54% decline from her June 2024 purchase price to today warrants scrutiny into whether subsequent developments—timing relative to the full-year loss, company announcements, or capital structure changes—explain the divergence from her prior pattern of well-timed accumulation at this ticker.